G
Gary J. Anthone
Researcher at University of Southern California
Publications - 37
Citations - 2823
Gary J. Anthone is an academic researcher from University of Southern California. The author has contributed to research in topics: Duodenal switch & Weight loss. The author has an hindex of 22, co-authored 36 publications receiving 2712 citations. Previous affiliations of Gary J. Anthone include Creighton University.
Papers
More filters
Journal ArticleDOI
Longitudinal Gastrectomy as a Treatment for the High-Risk Super-Obese Patient
TL;DR: Longitudinal gastrectomy is a safe and effective option for high-risk morbidly obese patients as an interim procedure to help decrease perioperative risk before duodenal switch procedure.
Journal ArticleDOI
Laparoscopic-assisted colectomy learning curve
Anthony J. Simons,Gary J. Anthone,Adrian E. Ortega,Morris E. Franklin,James W. Fleshman,W. Peter Geis,Robert W. Beart +6 more
TL;DR: This analysis, using total operative time as an indication of learning, shows that approximately 11 to 15 completed laparoscopic colectomies are needed to comfortably learn this procedure.
Journal ArticleDOI
Wound recurrence following laparoscopic colon cancer resection : Results of the American Society of Colon and Rectal Surgeons Laparoscopic Registry
Petar Vukasin,Adrian E. Ortega,Frederick L. Greene,Glenn D. Steele,Anthony J. Simons,Gary J. Anthone,Lynn A. Weston,Robert W. Beart +7 more
TL;DR: In this paper, the wound recurrence incidence is not increased by laparoscopic resection of colon cancer, and the authors hypothesized that recurrence rate is low even with open resection.
Journal ArticleDOI
Sleeve gastrectomy in the high-risk patient.
TL;DR: Although the sleeve gastrectomy does not result in as much weight loss as the duodenal switch or gastric bypass, it can be used as a stand-alone operation or as a bridge to more complex procedures in the high-risk super-obese patient.
Journal ArticleDOI
Follow-up of colorectal cancer: a meta-analysis.
TL;DR: It is concluded that intensive follow-up detects more recurrent cancers at a stage amenable to curative resection, resulting in an improvement in survival of recurrences and an increased overall five-year cumulative rate of survival.